差異的コファクター依存性は,人間の強化剤の異なるタイプを定義する
Christoph Neumayr1,2, Vanja Haberle1, Leonid Serebreni1,2
1Research Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.
Nature
|June 1, 2022
まとめ
研究者はヒトの増強剤を コファクターニーズによって分類し,一般的なタンパク質をバイパスする 異なるタイプを明らかにした. この発見は遺伝子調節と強化剤の特異性を理解するための新しい枠組みを提供します.
科学分野:
- ゲノミクス
- 分子生物学
- エピジェネティクス
背景:
- 多細胞生物は,主にゲノム強化剤によって調節される差異性遺伝子転写に依存する.
- 強化剤は転写因子を介してコファクターを採用するが,すべてのコファクターが普遍的に必要であるとは限らない.
- コファクター依存性に基づく異なる強化剤の存在は,以前は不明であった.
研究 の 目的:
- コファクター依存性に基づいて 人体強化剤を分類する.
- 増強剤の配列,クロマチンの多様性,遺伝子調節作用を理解するための枠組みを確立する.
- コファクターの枯渇による増強剤の活性変化を調査する.
主な方法:
- HCT116細胞におけるSTARR-seqを用いた全ゲノム強化剤の定量化.
- 8つのキーコファクターの急速な劣化後に評価された強化機能.
- 様々な強化剤の配列とクロマチンの性質を分析した.
主要な成果:
- 特定のコファクター要件,配列,およびクロマチンの特徴を持つ異なる強化剤タイプを特定した.
- 独立した転写プログラムを調節する,コアメディエーターサブユニットMED14またはBRD4から独立した強化剤を発見した.
- CCAAT/ TATAボックス遺伝子や熱ショック遺伝子には BRD4 が必要とされませんでした.
結論:
- コファクター依存性は,広く利用されているコファクターをバイパスできる異なるタイプを明らかにし,強化剤を分類する.
- 代替の転写活性化メカニズムは遺伝子発現プログラムを分離し,強化機能のための概念的枠組みを提供します.
- この分類は,増強剤の特異性と遺伝子発現における規制的役割の理解を高めます.
関連する概念動画
02:04Co-activators and Co-repressors
2.5K
2.5K
02:16Transcription Factors
77.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
77.8K
01:30General Transcription Factors
5.6K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.6K
02:33Combinatorial Gene Control
8.4K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.4K
02:36RNA Polymerase II Accessory Proteins
9.6K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.6K
02:23Master Transcription Regulators
7.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K